(1)
Seubwai, W.; Vaeteewoottacharn, K.; Umezawa, K.; Okada, S.; Wongkham, S. Enhanced Antitumor Activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters. SRIMEDJ 2013, 28, 171.